The DEA’s letter about THCa is bound to create more confusion in an already confusing area of law; however, it should properly be read as simply restating the fact that hemp producers must comply with the total THC test in order to harvest their hemp.

During its annual Supply Chain Conference, the DEA announced that it is “in the process of modifying its regulations” on cannabis constituents. In addition to discussing fentanyl and new synthetic opioids, the DEA addressed “synthetic cannabinoids”, which the DEA contends includes delta-8 THC derived from CBD in addition to “Spice” and “Bath Salts”.

North Carolina House Bill 563 appears to address many common concerns with the hemp-derived products industry. Will it survive the legislative process and be enacted as law?

Although the New York Cannabis Control Board is permitted by law to prohibit certain products or classes of products derived from cannabinoid hemp, it remains unclear how it would prohibit “high THC hemp products” that satisfy the definitions set forth in the state’s cannabis laws.